CT Scan + Sybil for Lung Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This research is being done to determine if an image-based deep learning model (Sybil) can accurately predict the likelihood of future lung cancer based on chest computed tomography (CT) imaging from individuals.
Who Is on the Research Team?
Allison Chang, MD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for people who have a family history of lung cancer. Participants should be able to undergo chest CT scans and do not have any specific exclusion criteria listed.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Trial Overview
The study is testing whether an artificial intelligence tool called Sybil can use chest CT scan images to predict the risk of developing lung cancer in the future.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants will undergo a single prospective low-dose non-contrast enhanced chest CT within 6 months of study enrollment.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.